182 related articles for article (PubMed ID: 15046388)
21. [PC SPES in prostatic cancer: critical review of the literature].
de la Taille A
Prog Urol; 2001 Jun; 11(3):428-32. PubMed ID: 11512453
[TBL] [Abstract][Full Text] [Related]
22. Ponicidin and oridonin are responsible for the antiangiogenic activity of Rabdosia rubescens, a constituent of the herbal supplement PC SPES.
Meade-Tollin LC; Wijeratne EM; Cooper D; Guild M; Jon E; Fritz A; Zhou GX; Whitesell L; Liang JY; Gunatilaka AA
J Nat Prod; 2004 Jan; 67(1):2-4. PubMed ID: 14738375
[TBL] [Abstract][Full Text] [Related]
23. Clinical models for testing chemopreventative agents in prostate cancer and overview of SELECT: the Selenium and Vitamin E Cancer Prevention Trial.
Klein EA
Recent Results Cancer Res; 2003; 163():212-25; discussion 264-6. PubMed ID: 12903856
[TBL] [Abstract][Full Text] [Related]
24. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
[TBL] [Abstract][Full Text] [Related]
25. Chinese herbal mixture PC SPES in treatment of prostate cancer (review).
Darzynkiewicz Z; Traganos F; Wu JM; Chen S
Int J Oncol; 2000 Oct; 17(4):729-36. PubMed ID: 10995884
[TBL] [Abstract][Full Text] [Related]
26. Largest-ever prostate cancer prevention trial.
FDA Consum; 2001; 35(5):8. PubMed ID: 11697103
[No Abstract] [Full Text] [Related]
27. The selenium and vitamin E cancer prevention trial.
Klein EA; Lippman SM; Thompson IM; Goodman PJ; Albanes D; Taylor PR; Coltman C
World J Urol; 2003 May; 21(1):21-7. PubMed ID: 12756490
[TBL] [Abstract][Full Text] [Related]
28. PC-SPES and prostate cancer.
Geliebter J; Mittelman A; Tiwari RK
J Nutr; 2001 Jan; 131(1):164S-166S. PubMed ID: 11208956
[No Abstract] [Full Text] [Related]
29. [Progress in research on PC-SPES anti-cancer agents in prostatic carcinoma in USA].
Zhang QH; Chen KJ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):295-9. PubMed ID: 12577362
[No Abstract] [Full Text] [Related]
30. Changes in serum proteomic patterns by presurgical alpha-tocopherol and L-selenomethionine supplementation in prostate cancer.
Kim J; Sun P; Lam YW; Troncoso P; Sabichi AL; Babaian RJ; Pisters LL; Pettaway CA; Wood CG; Lippman SM; McDonnell TJ; Lieberman R; Logothetis C; Ho SM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1697-702. PubMed ID: 16030104
[TBL] [Abstract][Full Text] [Related]
31. Clinical and biologic activity of an estrogenic herbal combination (PC-SPES) in prostate cancer.
DiPaola RS; Zhang H; Lambert GH; Meeker R; Licitra E; Rafi MM; Zhu BT; Spaulding H; Goodin S; Toledano MB; Hait WN; Gallo MA
N Engl J Med; 1998 Sep; 339(12):785-91. PubMed ID: 9738085
[TBL] [Abstract][Full Text] [Related]
32. SELECT: the selenium and vitamin E cancer prevention trial.
Klein EA; Thompson IM; Lippman SM; Goodman PJ; Albanes D; Taylor PR; Coltman C
Urol Oncol; 2003; 21(1):59-65. PubMed ID: 12684129
[TBL] [Abstract][Full Text] [Related]
33. PC Spes.
Med Lett Drugs Ther; 2001 Feb; 43(1098):15-6. PubMed ID: 11182805
[No Abstract] [Full Text] [Related]
34. Effects of a phytotherapeutic agent, PC-SPES, on prostate cancer: a preliminary investigation on human cell lines and patients.
de la Taille A; Hayek OR; Buttyan R; Bagiella E; Burchardt M; Katz AE
BJU Int; 1999 Nov; 84(7):845-50. PubMed ID: 10532984
[TBL] [Abstract][Full Text] [Related]
35. Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
Meuillet E; Stratton S; Prasad Cherukuri D; Goulet AC; Kagey J; Porterfield B; Nelson MA
J Cell Biochem; 2004 Feb; 91(3):443-58. PubMed ID: 14755676
[TBL] [Abstract][Full Text] [Related]
36. Unconventional therapy for prostate cancer: good, bad or questionable?
Nelson PS; Montgomery B
Nat Rev Cancer; 2003 Nov; 3(11):845-58. PubMed ID: 14668815
[No Abstract] [Full Text] [Related]
37. Chemoprevention: an important treatment option for prostate cancer.
Calvert RC; Thompson CS; Mikhailidis DP; Morgan RJ
J R Soc Promot Health; 2000 Sep; 120(3):146-7. PubMed ID: 11077795
[No Abstract] [Full Text] [Related]
38. PC-SPES: a brief overview.
Cordell GA
Integr Cancer Ther; 2002 Sep; 1(3):271-86. PubMed ID: 14667285
[TBL] [Abstract][Full Text] [Related]
39. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
Bonham M; Arnold H; Montgomery B; Nelson PS
Cancer Res; 2002 Jul; 62(14):3920-4. PubMed ID: 12124319
[TBL] [Abstract][Full Text] [Related]
40. Herbal therapy PC-SPES: in vitro effects and evaluation of its efficacy in 69 patients with prostate cancer.
de la Taille A; Buttyan R; Hayek O; Bagiella E; Shabsigh A; Burchardt M; Burchardt T; Chopin DK; Katz AE
J Urol; 2000 Oct; 164(4):1229-34. PubMed ID: 10992371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
